Cargando...
New and emerging therapies for acute and chronic graft versus host disease
Graft versus host disease (GVHD) remains a major cause of morbidity and mortality following allogeneic hematopoietic stem-cell transplantation (HSCT). Despite the use of prophylactic GVHD regimens, a significant proportion of transplant recipients will develop acute or chronic GVHD following HSCT. C...
Gardado en:
| Publicado en: | Ther Adv Hematol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
SAGE Publications
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5753923/ https://ncbi.nlm.nih.gov/pubmed/29317998 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620717741860 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|